Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 05, 2020 09:15 ET | Source: RAFARMA PHARMACEUTICALS INC

Letter to Shareholders Regarding Rafarma Acquisition by R. & D. Biocogency Laboratories Inc.

Ljubljana, Slovenia, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) presents the following letter to Rafarma shareholders from CEO Vladimir Dolgolenko: To Our...